Sunday, July 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 57 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 9125922

    Phosphate esters of gyrase and topoisomerase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  2. US 9127021

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  3. US 9126956

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  4. US 9120747

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted

  5. US 9120744

    Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted

  6. US 9119837

    Use of sEH inhibitors as analgesics

    The Regents of the University of California · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted

  7. US 9120790

    Azaindoles useful as inhibitors of Janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted

  8. US 9120758

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted

  9. US 9108934

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted

  10. US 9096602

    Substituted pyrrolo[2,3-B]pyrazines as ATR kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  11. US 9096584

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  12. US 9096501

    Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  13. US 9096625

    BCL-2/BCL-XL inhibitors and therapeutic methods using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  14. US 9096609

    Macrocyclic LRRK2 kinase inhibitors

    Oncodesign SA · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  15. US 9096542

    Kinase inhibitors and their uses

    Rigel Pharmaceuticals, Inc. · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  16. US 9096496

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  17. US 9095593

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  18. US 9090597

    Pyrazolone derivatives as PDE4 inhibitors

    TAKEDA GMBH · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  19. US 9090589

    Specific nNOS inhibitors for the therapy and prevention of human melanoma

    The Regents of the University of California · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  20. US 9089545

    Small molecule RNase inhibitors and methods of use

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  21. US 9090630

    Macrocyclic FLT3 kinase inhibitors

    Oncodesign SA · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  22. US 9084782

    Chemical inhibitors of cholesterol biosynthesis and venous angiogenesis

    The Regents of the University of California · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  23. US 9079898

    Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jul 14, 2015 · Expires Jul 9, 2035

    granted

  24. US 9079944

    Influenza A virus vaccines and inhibitors

    The Board of Regents of the University of Texas System · Granted Jul 14, 2015 · Expires Jul 9, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.